Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Unravelling the atomic structure and dynamics of amyloidogenic light-chain antibodies using NMR spectroscopy

EF 2016-17

Résumé
Most of the biological activities in the cell are performed by proteins that adopt a special three-dimensional fold for proper function. However, in many cases proteins can misfold inside the cell forming pathological species which can lead to many diseases. One major group of diseases, related to protein misfolding, is called Amyloidosis in which the misfolded proteins form long fibrils, known as amyloids that can deposit on different organs in the body leading to organ malfunction and often death. The most common form of amyloidosis in western countries is the so-called Light Chain Amyloidosis (AL amyloidosis), which is responsible for 10 deaths per million every year. In AL amyloidosis the most prevalent antibody in human serum misfolds and aggregates on different organs including the heart, kidney, peripheral nerves and liver. Despite the fact that this form of amyloidosis was the first to be identified, the molecular mechanism behind AL amyloidosis remains unknown. The elusive molecular mechanism of this disease has made it difficult to develop effective ways of early diagnosis and treatment and most patients are presented to the clinic at a late stage. Here, I aim to use a powerful method, namely, Nuclear Magnetic resonance (NMR), to scrutinize the structure and dynamics of the unfolded antibody responsible for disease. Over the years, NMR has proven to be the method-of-choice to dissect the atomic structure and dynamics of proteins in different environments. The work proposed here will help to develop more efficient ways for the diagnosis and treatment of AL amyloidosis.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
362098
Name
Kaplan Mohammed
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Unravelling the atomic structure and dynamics of amyloidogenic light-chain antibodies using NMR spectroscopy
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Amyloidosis; Antibody; Nuclear Magnetic Resonance; Organ Malfunction; Protein Misfolding
Abstract
Most of the biological activities in the cell are performed by proteins that adopt a special three-dimensional fold for proper function. However, in many cases proteins can misfold inside the cell forming pathological species which can lead to many diseases. One major group of diseases, related to protein misfolding, is called Amyloidosis in which the misfolded proteins form long fibrils, known as amyloids that can deposit on different organs in the body leading to organ malfunction and often death. The most common form of amyloidosis in western countries is the so-called Light Chain Amyloidosis (AL amyloidosis), which is responsible for 10 deaths per million every year. In AL amyloidosis the most prevalent antibody in human serum misfolds and aggregates on different organs including the heart, kidney, peripheral nerves and liver. Despite the fact that this form of amyloidosis was the first to be identified, the molecular mechanism behind AL amyloidosis remains unknown. The elusive molecular mechanism of this disease has made it difficult to develop effective ways of early diagnosis and treatment and most patients are presented to the clinic at a late stage. Here, I aim to use a powerful method, namely, Nuclear Magnetic resonance (NMR), to scrutinize the structure and dynamics of the unfolded antibody responsible for disease. Over the years, NMR has proven to be the method-of-choice to dissect the atomic structure and dynamics of proteins in different environments. The work proposed here will help to develop more efficient ways for the diagnosis and treatment of AL amyloidosis.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kaplan, Mohammed
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~